NAMS

NASDAQ · Biotechnology

Newamsterdam Pharma Co Nv

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$31.01

+0.95 (+3.16%)

As of Mar 25, 9:57 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 19 90%

Hold 2 10%

Sell 0 0%

Price Target

Analyst Price Target +17.3% upside

Low Target $23.00

Average Target $36.39

High Target $47.36

Current Price $31.01

Current
$31.01

Target
$36.39

$23.00 $36.39 avg $47.36

Scenario Analysis

Bear Case

$23.00

-25.8%

Low target

Base Case

$36.39

+17.3%

Avg target

Bull Case

$47.36

+52.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$42.00

-26.2% from high

52-Week Low

$14.06

+120.6% from low

50-Day SMA

$34.11

-9.1% vs SMA

200-Day SMA

$28.53

+8.7% vs SMA

RSI (14)

66.1

Neutral

Target vs 52W High

$36.39

-13.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%